Post-earnings recap
Reported
Tue, Feb 27, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
ACADIA Pharmaceuticals reported a loss of $0.55 per share, which was below expectations. The stock reacted negatively, declining by 3.62%. The lack of revenue figures and guidance may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.55 | N/A | -0.87% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, and the analysis is based solely on numerical results.